214 related articles for article (PubMed ID: 29750576)
1. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
[TBL] [Abstract][Full Text] [Related]
2. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
[TBL] [Abstract][Full Text] [Related]
3. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.
Fuks F; Hurd PJ; Deplus R; Kouzarides T
Nucleic Acids Res; 2003 May; 31(9):2305-12. PubMed ID: 12711675
[TBL] [Abstract][Full Text] [Related]
4. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.
Yang Y; Liu R; Qiu R; Zheng Y; Huang W; Hu H; Ji Q; He H; Shang Y; Gong Y; Wang Y
Oncogene; 2015 Jan; 34(1):104-18. PubMed ID: 24292684
[TBL] [Abstract][Full Text] [Related]
5. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
Cai L; Ma X; Huang Y; Zou Y; Chen X
Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
[TBL] [Abstract][Full Text] [Related]
7. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
[TBL] [Abstract][Full Text] [Related]
8. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.
Zhao M; Wu X; Zhang Q; Luo S; Liang G; Su Y; Tan Y; Lu Q
Arthritis Res Ther; 2010; 12(6):R227. PubMed ID: 21192791
[TBL] [Abstract][Full Text] [Related]
9. Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer.
Kang MY; Lee BB; Kim YH; Chang DK; Kyu Park S; Chun HK; Song SY; Park J; Kim DH
Int J Cancer; 2007 Nov; 121(10):2192-7. PubMed ID: 17657744
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
11. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
12. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
13. The histone methyltransferase Suv39h regulates 3T3-L1 adipogenesis.
Jing J; Li F; Zha L; Yang X; Wu R; Wang S; Xue B; Shi H
Adipocyte; 2020 Dec; 9(1):401-414. PubMed ID: 32698678
[TBL] [Abstract][Full Text] [Related]
14. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of SUV39H1 gene specific siRNA in human leukemia cell line].
Zhao T; Ma XD; Huang YQ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):49-54. PubMed ID: 23597465
[TBL] [Abstract][Full Text] [Related]
16. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
17. PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation.
Kim G; Bhattarai PY; Lim SC; Kim JY; Choi HS
Cancer Lett; 2021 Feb; 499():164-174. PubMed ID: 33253791
[TBL] [Abstract][Full Text] [Related]
18. Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4
Luo S; Zhang H; Xie Y; Huang J; Luo D; Zhang Q
Clin Epigenetics; 2022 Dec; 14(1):181. PubMed ID: 36536372
[TBL] [Abstract][Full Text] [Related]
19. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells.
Tsuchiya Y; Naito T; Tenno M; Maruyama M; Koseki H; Taniuchi I; Naoe Y
J Leukoc Biol; 2016 Aug; 100(2):327-38. PubMed ID: 26896487
[TBL] [Abstract][Full Text] [Related]
20. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR.
Kamoi K; Yamamoto K; Misawa A; Miyake A; Ishida T; Tanaka Y; Mochizuki M; Watanabe T
Retrovirology; 2006 Jan; 3():5. PubMed ID: 16409643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
